Hjem › Epitelcellekarcinom i eggstokkene › Texas › Houston
Kliniske studier for Epitelcellekarcinom i eggstokkene i Houston, TX
6 studier for Epitelcellekarcinom i eggstokkene søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekruttererFase 2
- Houston Methodist Hospital /ID# 274568, Houston
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
RekruttererFase 1
- Site 0103, Houston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruttererFase 1/2
- MD Anderson Cancer Center, Houston
A Study of NX-1607 in Adults With Advanced Malignancies
RekruttererFase 1
- MD Anderson Cancer Center, Houston
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RekruttererFase 1
- MD Anderson Cancer Center, Houston
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
RekruttererFase 1
- The University of Texas M.D. Anderson Cancer Center, Houston
Epitelcellekarcinom i eggstokkene-studier i andre byer
- Durham, NC8 studier
- Boston, MA8 studier
- New York City, NY7 studier
- San Diego, CA7 studier
- Chicago, IL7 studier
- Baltimore, MD6 studier
- Philadelphia, PA6 studier
- Cleveland, OH6 studier
- Minneapolis, MN5 studier
- Salt Lake City, UT5 studier
- Portland, OR5 studier
- Edison, NJ5 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.